Pyxis Oncology/$PYXS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Pyxis Oncology
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
Ticker
$PYXS
Sector
Primary listing
Employees
44
Headquarters
Website
Pyxis Oncology Metrics
BasicAdvanced
$76M
-
-$1.57
-
-
Price and volume
Market cap
$76M
52-week high
$4.61
52-week low
$0.83
Average daily volume
375K
Financial strength
Current ratio
5.654
Quick ratio
5.201
Long term debt to equity
20.417
Total debt to equity
22.206
Profitability
EBITDA (TTM)
-80.537
Gross margin (TTM)
100.00%
Net profit margin (TTM)
-3,414.40%
Operating margin (TTM)
-2,939.89%
Effective tax rate (TTM)
1.92%
Revenue per employee (TTM)
$60,000
Management effectiveness
Return on assets (TTM)
-31.25%
Return on equity (TTM)
-74.80%
Valuation
Price to revenue (TTM)
26.712
Price to book
0.87
Price to tangible book (TTM)
0.9
Price to free cash flow (TTM)
-1.021
Free cash flow yield (TTM)
-97.91%
Free cash flow per share (TTM)
-1.204
Growth
Revenue change (TTM)
-82.53%
Earnings per share change (TTM)
30.95%
3-year earnings per share growth (CAGR)
-24.60%
What the Analysts think about Pyxis Oncology
Analyst ratings (Buy, Hold, Sell) for Pyxis Oncology stock.
Pyxis Oncology Financial Performance
Revenues and expenses
Pyxis Oncology Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Pyxis Oncology stock?
Pyxis Oncology (PYXS) has a market cap of $76M as of August 18, 2025.
What is the P/E ratio for Pyxis Oncology stock?
The price to earnings (P/E) ratio for Pyxis Oncology (PYXS) stock is 0 as of August 18, 2025.
Does Pyxis Oncology stock pay dividends?
No, Pyxis Oncology (PYXS) stock does not pay dividends to its shareholders as of August 18, 2025.
When is the next Pyxis Oncology dividend payment date?
Pyxis Oncology (PYXS) stock does not pay dividends to its shareholders.
What is the beta indicator for Pyxis Oncology?
Pyxis Oncology (PYXS) does not currently have a Beta indicator.